JAGX vs JCI · rev $1.2M vs P/E 44, rev $23.60B
Jaguar Animal Health Inc (JAGX) versus Johnson Controls International PLC (JCI) — a side-by-side from cached financials, not a winner call.
Jaguar Animal Health Inc (JAGX) is a biotechnology company listed on NASDAQ.
Johnson Controls International PLC (JCI) is a building products & equipment company listed on NYSE.
Latest reported JAGX revenue for 2026-06-30 was $1.2M. Net income was -$12.8M. Revenue was down 94.0% from 2026-03-31 to 2026-06-30. JAGX currently screens at market cap $1.7M.
Latest reported JCI revenue for 2025-09-30 was $23.60B. Net income was $3.51B. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
JAGX currently screens at market cap $1.7M. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
Not investment advice. Open the JAGX and JCI stock pages for the full models.
Not investment advice.